Italy: expenditure on orphan drugs 2017, by ATC
This statistic depicts the distribution of orphan drugs expenditure in Italy in 2017, by ATC. According to data, orphan drugs classified under the category L of the ATC, namely antineoplastic and immunomodulating agents, accounted for the greatest share of spending (58.7 percent).